CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-13 | Finizio Robert G CEO | Sale | −92,000 | $4.81 | $442K | 18,393,559 |
| 2018-11-13 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 552,910 | ||
| 2018-11-12 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-11-12 | Finizio Robert G CEO | Sale | −92,000 | $4.73 | $435K | 18,393,559 |
| 2018-11-12 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 644,910 | ||
| 2018-11-09 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-11-09 | Bernick Brian Director | Sale | −91,400 | $4.83 | $441K | 6,557,371 |
| 2018-11-09 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 548,100 | ||
| 2018-11-08 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-11-08 | Bernick Brian Director | Sale | −91,400 | $4.93 | $450K | 6,557,371 |
| 2018-11-08 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 640,310 | ||
| 2018-11-07 | Cartwright Daniel A CFO | Exercise or conversion | +40,000 | $0.38 | $15K | 40,000 |
| 2018-11-07 | Cartwright Daniel A CFO | Sale | −40,000 | $4.85 | $194K | 0 |
| 2018-11-07 | Cartwright Daniel A CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 220,000 | ||
| 2018-10-26 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-10-26 | Finizio Robert G CEO | Sale | −92,000 | $5.12 | $471K | 18,393,559 |
| 2018-10-26 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 736,910 | ||
| 2018-10-25 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-10-25 | Finizio Robert G CEO | Sale | −92,000 | $5.45 | $501K | 18,393,559 |
| 2018-10-25 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 828,910 |
Page 19 of 24 · 463 trades